MSD has entered an exclusive global licence agreement with Hansoh Pharma for a p...
The US FDA has approved Ionis' TRYNGOLZA (olezarsen) as an adjunct to diet for r...
Novo Nordisk has announced positive results from its Phase III trial of CagriSem...
The US Food and Drug Administration (FDA) has stood by an earlier decision confi...
The UK's DHSC has announced its anticipated 2025 headline payback rate for new m...
Picking the right clinical partners will be critical for oncology innovators hop...
Improper advertising on media constituted a large part of traffic directed to th...
Gilead Sciences has entered a strategic partnership with Terray for the discover...
Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authorit...
Construction has already begun on the Ozempic-producer’s new Denmark production ...
Novo Holdings has completed the previously announced acquisition of Catalent in ...
A new report identifies data content management as the primary driver of growth ...
Industrial refrigeration is key to the healthcare industry, but it contributes m...
Abera and Orexo have entered a partnership to develop and test the powder formul...
After Amylyx and PTC, Corcept has also decided to withdraw from the amyotrophic ...
